ShredMAX – SLU-PP-332 Capsules

Description

SLU-PP-332 Capsules Formulated for Mitochondrial Output.

Most fat-loss supplements rely on stimulants or thermogenic compounds that increase caloric output through stress on the cardiovascular system. ShredMAX works differently — targeting the ERR nuclear receptor family to activate the same mitochondrial gene programs that aerobic exercise turns on.

Benefits & Function

SLU-PP-332 (100 mg)

• Supports mitochondrial biogenesis and cellular energy output
• Promotes fatty acid oxidation and metabolic efficiency
• Helps maintain exercise capacity and endurance as part of a training routine

Ingredients

Each serving contains SLU-PP-332 100 mg.

Other ingredients: vegetarian capsule (hydroxypropyl methylcellulose), microcrystalline cellulose, rice hull

Serving size: 1 capsule | Servings per container: 120

Who Is ShredMAX For?

• People focused on fat metabolism and body composition who train consistently
• Those looking to support mitochondrial output alongside an active lifestyle
• Anyone who wants a stimulant-free alternative to support endurance and metabolic efficiency
• Experienced supplement users building a comprehensive performance and fat-loss protocol

Suggested Use

Take 1 capsule in the morning, with or without food. More experienced users may take 1 capsule twice daily. Do not exceed 6 capsules per day. Use consistently alongside regular exercise for best results. Cycling guidance available in the product documentation.

If you are pregnant, nursing, taking medication, or managing a medical condition, consult a qualified healthcare provider before use.

Quality and Purity

• Manufactured in a cGMP-certified facility
• Third-party tested for purity and potency
• No artificial colors, fillers, or preservatives
• Non-GMO ingredients
• Vegetarian capsule with clean excipient profile

FAQ

How is ShredMAX different from a standard fat burner?

Standard fat burners primarily use stimulants to increase heart rate and thermogenesis. ShredMAX targets ERR alpha, beta, and gamma — nuclear receptors that regulate mitochondrial gene expression — to support fatty acid oxidation and endurance at the cellular level, without relying on stimulant pathways.

Can I stack ShredMAX with other BioLongevity products?

ShredMAX pairs well with most BioLongevity formulas. It is not recommended to combine ShredMAX with other SLU-PP-332-containing products. If you are taking cardiovascular or metabolic medications, consult your healthcare provider before adding ShredMAX to your protocol.

How long before I notice results?

Mitochondrial adaptations take time to accumulate. Most users report noticeable changes in training output and body composition within 4 to 8 weeks of consistent use alongside exercise. Metabolic markers may shift sooner.

Why start with one capsule?

Starting with 1 capsule daily allows you to assess individual response before progressing dose. ERR activation is dose-dependent, and incremental titration gives your system time to adapt before higher daily doses.

Is ShredMAX appropriate for ongoing use?

ShredMAX is designed for consistent use during active training phases. Follow the cycling guidance in the product documentation. If you have a medical condition or take prescription medications, discuss long-term use with your healthcare provider.

Clinical Research

1. Billon et al. (2023). Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chemical Biology. https://doi.org/10.1021/acschembio.2c00720
2. Billon et al. (2024). A Synthetic ERR Agonist Alleviates Metabolic Syndrome. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.123.001733
3. Billon et al. (2025). An Orally Active Estrogen Receptor-Related Receptor Agonist, SLU-PP-915, Enhances Aerobic Exercise Capacity. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/j.jpet.2025.103787
4. de Souza-Lima et al. (2026). Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications. Revista Medica de Chile. https://doi.org/10.4067/s0034-98872026000200237
5. Okda et al. (2026). Chemical Optimization of the Exercise Mimetic SLU-PP-332 Enables Insight Into Estrogen-Related Receptor Signaling. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2026.151450